A Green, Facile Method for Selective α‑Bromination of Flavanones Authors: Anna J. Sigmon, Tatiana N. Laremore, Hemant Yennawar, Gracie Clare Guerin, Brendan Pelletier, Samreen Dallal, Sameer Aggroia, Maria Englert, Christy George Published: 2025 ABSTRACT Flavonoids, a broad class of polyphenolic secondary metabolites, possess diverse and potent biological activities, including anti-inflammatory, antioxidative, antiviral, and analgesic properties. Flavanones, a prominent flavonoid subclass, are especially notable for their therapeutic potential, with several derivatives exhibiting anticancer and antiviral effects. Bromination is a valuable strategy in drug development, as halogenation can enhance biological activity and provide synthetic handles for further molecular elaboration. While aromatic bromination of flavonoids is known, selective α-bromination of flavanones, particularly those bearing hydroxy and alkoxy substituents, remains underexplored due to electronic and oxidative challenges. In this study, we investigated the selective α-bromination of hydroxy- and alkoxy-substituted flavanones, generating novel brominated derivatives. We identified a mild, green protocol for α-bromination of a range of monosubstituted flavanones in good yields using copper­(II) bromide in ethyl acetate. The α-bromination of flavanones bearing multiple hydroxyl groups resulted in poor selectivity and competing nuclear bromination, underscoring the challenges posed by increased aromatic nucleophilicity. Novel products were characterized using a combination of nuclear magnetic resonance (NMR) spectroscopy, high-resolution mass spectrometry (HRMS), tandem electrospray ionization mass spectrometry (ESI-MS/MS), and X-ray crystallography. These findings expand the chemical space of flavanone derivatives and provide valuable intermediates for the synthesis of pharmacologically relevant heterocycles. Introduction Flavonoids are a diverse class of polyphenolic secondary metabolites widely distributed throughout the plant kingdom. They exhibit notable biological activitiesincluding anti-inflammatory, antioxidative, antiviral, and analgesic propertiespositioning them as promising candidates for medicinal applications. Among the various structural subclasses of flavonoids, flavanones are particularly noteworthy for their prevalence in bioactive compounds (Figure ). − For example, HLBT-100 (Figure A) was reported to exhibit submicromolar activity against solid and hematological cancers, and 5-hydroxy-7-methoxy-6-methylflavanone has been found to inhibit the dengue virus (Figure C). Biologically active flavanone derivatives with significant biological activity. (A) HLBT-100 exhibits in vitro submicromolar activity against both solid and hematological cancers; (B) exhibits anti-inflammatory properties; (C) inhibits dengue virus; and (D) is a promising pain treatment. The bromination of natural products is a valuable synthetic transformation because it can enhance or modify a compound’s intrinsic biological properties. Indeed, a significant proportion of bioactive compounds contain halogen atoms, making halogenation an important synthetic tool in drug discovery. For example, 4′-bromo-5,7-dimethoxyflavanone has anti-inflammatory properties (Figure B) and 3,3-dibromoflavanone exerts antinociceptive effects without inducing sedation, anxiety, or motor incoordination (Figure D). ,, In another example, brominated quercetin derivatives have been reported to have improved anticancer activity compared to unbrominated quercetin. In addition to potentially modifying biological activity, α-bromination is useful because it introduces a functional handle for further modifications, enabling transformations into a wide variety of derivatives, such as selenium derivatives and N, S, and O-heterocycles, which are known pharmacophores (Figure ). − Representative transformations of α-brominated ketones into selenium derivatives and heterocycles. Aromatic bromination of flavonoids has been widely reported using a variety of brominating agents. − By contrast, there is far less precedent for the α-bromination of flavanones, with the most common examples using unsubstituted or halogenated flavanones with copper­(II) bromide, pyrrolidone hydrotribromide, or molecular bromine (Scheme ). − Reports on the α-bromination of flavanones bearing alkoxy substituents are very limited and have not been reported in green solvents under ambient air. , And to our knowledge, no successful α-bromination has been documented for flavanones with free hydroxyl groups under any conditions. The selective α-bromination of flavanones containing hydroxy and alkoxy groups poses distinct challenges due to (i) competing nuclear bromination of the electron-rich aromatic rings and (ii) the susceptibility of phenolic groups to oxidation. The present work expands the scope of copper-mediated halogenation into a structurally complex and biologically important flavonoid class. Reported α-Halogenations of Unsubstituted and Halogenated Flavanones We anticipated that the electron-donating nature of hydroxyl and alkoxy substituents on flavanones might hinder their selective α-halogenation owing to the increased nucleophilicity of the aromatic rings (Scheme ). In addition, because brominating reagents are oxidizing in nature, we expected that side reactions could occur via oxidation of the phenol or oxygen-containing ring. Herein, we report our efforts toward the selective α-bromination of a variety of hydroxy- and alkoxy-substituted flavanones. The resulting brominated products are novel, and their characterization is reported using a combination of nuclear magnetic resonance (NMR) spectroscopy, high-resolution mass spectroscopy (HRMS), electrospray ionization tandem mass spectrometry (ESI MS–MS), and X-ray crystallography. Competing Halogenation Pathways Results and Discussion Given the limited precedent for α-bromination of flavanones bearing hydroxy or alkoxy substitution, we first performed a broad screening of bromination conditions using 6-methoxyflavanone as the model substrate; to the best of our knowledge, the α-bromination of this substrate has not been previously reported. A wide range of brominating reagents were employed, including N-bromosuccinimide (NBS), copper­(II) bromide, pyrrolidone hydrotribromide (PHT), pyridinium tribromide (PTB), and trimethylphenylammonium tribromide (PTAB) (Table ). All reactions were performed under an ambient air atmosphere. Most reagents screened resulted in moderate to excellent conversions, with the exception of NBS in diethyl ether, which primarily furnished unreacted starting material. 1Screening of Bromination Conditions for α-Bromination of 6-Methoxyflavanone entry bromine source solvent, temp, and time (h) additive percent conversion 1 CuBr2 CHCl3/EtOAc (1:1), reflux, 2 hnone73% 2 CuBr2 CHCl3/EtOAc (1:1), r.t., 24 hnone79% 3 CuBr2 EtOAc, reflux, 2 hnone96% 4 NBS (added in one portion)Et2O, r.t., 1.5 hNH4OAc20% 5 NBS (added in four portions)methanol, reflux, 1 hsilica gel86% 6 NBS (added in four portions)methanol, reflux, 1 hneutral Al2O3 83.5% 7 NBS (added in four portions)methanol, reflux, 1 hacidic Al2O3 70% 8 NBSmethanol, reflux, 1 hnone87% 9 NBSethanol, reflux, 1 hP-TsOH85% 10 PHTTHF, reflux, 15 minnone97.5% 11 PHTacetic acid, r.t., 24 hnone97% 12 PTBacetic acid, r.t., 2 hnone99% 13 PTBmethanol, reflux, 1 hnone99% 14 PTBethanol, reflux, 1 hnone79% 15 PTABTHF, r.t., 45 minnone90%aPercent conversion calculated from HPLC-UV traces as area of product ÷ (area of SM + area of products), uncorrected for differing ultraviolet (UV) responses. Screening of Bromination Conditions for α-Bromination of 6-Methoxyflavanone Percent conversion calculated from HPLC-UV traces as area of product ÷ (area of SM + area of products), uncorrected for differing ultraviolet (UV) responses. Although most reagents resulted in high conversion, examination of high-performance liquid chromatography (HPLC) UV traces revealed varying amounts of byproducts alongside the mass for the desired product. The masses of the most common byproducts matched flavones A and B, as well as dibrominated flavanone C (Figure ). This indicates that competitive oxidations can occur concurrently with α-bromination. Byproducts from nuclear bromination were not detected in the NMR spectra. Byproducts observed during the bromination of 6-methoxyflavanone. Trials using NBS as the bromination source produced the most complex HPLC chromatograms with the highest levels of undesired byproducts. Based on guidance from the literature, various additives were screened in combination with NBS to promote either the formation of an electrophilic bromine species or to promote the formation of an an enol intermediate, which could then undergo selective α-bromination. , Those additives included p-toluenesulfonic acid, silica gel, acidic aluminum oxide, neutral aluminum oxide and ammonium acetate. However, none of these additives improved the results. Gratifyingly, trials using copper­(II) bromide in ethyl acetate and PTB in methanol revealed clean HPLC-UV traces which featured two major product peaks matching the mass of the desired product. The two major peaks corresponded to cis/trans isomers, as determined by 1H NMR. To unambiguously determine the structure of the major product formed from the reaction of 6-methoxyflavanone with copper­(II) bromide in ethyl acetate (Table , entry 3), the product was recrystallized from ethanol and analyzed by X-ray crystallography, where it was revealed to be the desired α-brominated flavanone (Figure ). Although both cis and trans α-brominated products were isolated as determined by 1H NMR, only the cis isomer selectively crystallized. The bromine atom exhibited an axial-type orientation whereas the phenyl group was disposed equatorially. X-ray structure of cis-3-bromo-6-methoxyflavanone. The literature suggests that one possible mechanism for α-bromination with copper­(II) bromide involves a copper enolate intermediate (Scheme ). This enolate may be formed by coordination of the Lewis acidic copper to the carbonyl oxygen, followed by abstraction of an alpha hydrogen by one of the bromide ligands on the copper. A second equivalent of copper­(II) bromide acts as the source of electrophilic bromine in the second step. In this possible pathway, two equivalents of copper­(II) bromide are required and copper­(I) bromide and HBr are byproducts. , Given that copper­(I) bromide and HBr can readily oxidize to copper­(II) bromide in the presence of oxygen, substoichiometric amounts of copper­(II) bromide were tried since the reactions were being performed under ambient air. However, incomplete conversions of the starting material were obtained when less than two equivalents of copper­(II) bromide were used. Possible Mechanism for α-Bromination Reaction with Copper­(II) Bromide To our delight, the two most effective reaction conditions employed green solvents and profoundly less toxic brominating agents than elemental bromine. Although the literature advises that copper­(II) bromide yields the cleanest reactions when used in a mixture of chloroform and ethyl acetate, we found superior results using ethyl acetate alone. This is advantageous in that we can eliminate the use of highly toxic chloroform as a cosolvent. Copper­(II) bromide also offers a practical advantage over pyridinium tribromide; it can be added in a single portion at the start of the reaction, whereas pyridinium tribromide must be introduced incrementally to prevent overbromination. Given these benefits, we extended the use of copper­(II) bromide to additional flavanone substrates (Table ). 2α-Bromination of Diverse Flavanones Using 2 Equiv of Copper­(II) Bromide in Ethyl AcetateaYield includes major product plus minor amount of flavone byproduct.bCis/trans ratios determined from 1H NMR. α-Bromination of Diverse Flavanones Using 2 Equiv of Copper­(II) Bromide in Ethyl Acetate Yield includes major product plus minor amount of flavone byproduct. Cis/trans ratios determined from 1H NMR. The optimized conditions furnished α-brominated products in good to excellent isolated yields for 5-methoxy, 6-methoxy-, 7-methoxy-, 4′-methoxy-, and 6-hydroxyflavanones (Table ; entries 1–5). The products were mixtures of cis/trans isomers, with the ratios determined by 1H NMR integration of the corresponding doublets relating to C2–H and C3–H coupling (Figure ). In most cases, there was a preference for the cis isomer, consistent with previous observations of the α-bromination of 2-substituted chroman-4-ones. , The preference for the cis isomer is likely due to its greater thermodynamic stability. Previous computational studies on the cis/trans isomers of 3,8-dibromo-6-chloro-2-phenethylchroman-4-one showed that the most stable isomer was the cis isomer wherein the bromine occupies an axial position and the phenethyl group is in an equatorial position. This axial orientation of the bromine was also observed in the crystal structures we obtained for cis-3-bromo-6-methoxyflavanone and cis-3-bromo-4′-methoxyflavanone (Figures and ). While the cis isomer is likely the thermodynamic product, it may not be the kinetic product. Prior studies have reported a preference for the trans isomer when reactions are performed at lower temperatures, suggesting that the trans isomer may be formed first and then isomerized to the more stable cis isomer via enolization. Cis/trans isomers give distinctive doublets with significantly different coupling constants. X-ray structures of α-brominated methoxy-substituted flavanones. In addition to NMR analysis, X-ray structures were obtained for 3-bromo-5-methoxyflavanone, 3-bromo-4′-methoxyflavanone, and 3-bromo-7-methoxyflavanone (Figure ). For 3-bromo-5-methoxyflavaone, two stereoisomers were superimposed upon each other in the asymmetric unit. For all other derivatives, only one isomer occupied the asymmetric unit. Although the reactions with a flavanone containing a free hydroxyl group also produced the α-brominated product as the major product (Table , entry 5), the product was not as clean as the alkoxy-substituted flavanones and contained minor amounts of byproduct. The structure of that minor byproduct for the reaction with 6-hydroxyflavanone was unambiguously determined via X-ray crystallography to be 6-hydroxyflavone (Figure ). X-ray structure of flavone byproduct isolated from the α-bromination of 6-hydroxyflavanone. Unfortunately, when multiple hydroxyl groups were present on one of the aromatic rings, complex mixtures formed, and selective α-bromination did not occur. For example, attempts to α-brominate 5,6-dihydroxyflavanone furnished a complex mixture of products, including nuclear brominated products. Experiments with naringenin yielded a mixture of unreacted starting material and nuclear brominated products, with no α-bromination observed. High-resolution MS/MS analysis of a monobrominated naringenin [M + H]+ ion at 351 m/z resulted in three major fragment ions with m/z 230.9286, 147.0438, and 119.0490. The proposed fragment structures and their monoisotopic masses are shown in Scheme . This indicates that bromination selectively occurs on the aromatic ring of naringenin that contains two hydroxyl groups. Observed Fragmentation of Brominated Naringenin via Tandem MS–MS Experiments Nuclear bromination of aromatic compounds with copper­(II) bromide has been previously reported, although not with naringenin. Mechanistically, the reaction cannot be proceeding through a copper enolate since alpha bromination is not observed. Instead, it is plausible that nuclear bromination occurs via an electrophilic aromatic substitution with elemental bromine. Copper­(II) bromide has been reported to exist in equilibrium with bromine and copper­(I) bromide, albeit with the equilibrium strongly favoring the reactants (Scheme ). Nonetheless, if a small quantity of bromine is present in solution and reacts with the electron-rich flavanone, that irreversible removal of bromine may shift the equilibrium to the right and provide enough bromine to produce observable products. Equilibrium between Copper­(II) Bromide and Elemental Bromine For the sake of comparison, pyridinium tribromide in acetic acid was also tried with naringenin with the hope of favoring enol formation in acidic media; however, exclusive nuclear bromination was again obtained. Attempts to decrease the nucleophilicity of the aromatic rings of naringenin by acylating its hydroxy groups did not produce the desired α-brominated product (Scheme ). In addition, the hydroxyl groups were silylated with tert-butyldimethylsilyl chloride in an attempt to sterically disfavor aromatic bromination, but this also failed to produce α-brominated products. Failed Attempts to Electronically or Sterically Disfavor Nuclear Bromination In summary, we have developed a mild, green, and air-stable method for the synthesis of novel α-brominated derivatives of hydroxy- and alkoxy-substituted flavanones in good yields. This method employs operationally simple, environmentally benign conditionsusing ethyl acetate as a green solvent and copper­(II) bromide as a less hazardous brominating agentwhile avoiding the need for toxic cosolvents or harsh reagents. Structural elucidation via single-crystal X-ray diffraction, ESI-MS/MS and NMR confirmed the identity and stereochemistry of the products, including the consistent preference for the cis isomer. This work expands the synthetic toolbox for late-stage functionalization of flavonoids, a class of compounds with well-established pharmacological relevance. The α-brominated flavanones synthesized here not only represent new chemical entities with potential medicinal relevance, but they also serve as versatile intermediates for the construction of diverse heterocyclic scaffolds, including N-, O-, and S-heterocycles. These scaffolds are foundational in medicinal chemistry and drug discovery, underscoring the broader utility of this methodology. Ongoing computational studies aim to elucidate the mechanistic pathway for the copper-mediated reaction, which may reveal new insights into possible ways for minimizing aromatic halogenation. Overall, this study provides a valuable contribution to the field of green halogenation chemistry and opens new avenues for the synthesis of bioactive flavonoid derivatives with potential therapeutic applications. Experimental Section General Experimental Procedures All starting materials and solvents were obtained commercially and used without further purification. Analytical thin-layer chromatography was performed on silica gel 60 F254 plates and visualized under UV light (254 nm). Purifications were performed via column chromatography on silica gel 60 (40–63 μm). NMR: 1D 1H and 13C spectra were recorded on a Bruker Avance NanoBay NEO-400 MHz, a Bruker Avance III HD 500 MHz spectrometer equipped with a Prodigy probe or a Bruker Avance III 600 MHz spectrometer equipped with a triple cryo interface cryoprobe. Chemical shifts values were internally referenced to residual solvent peaks. NMR chemical shifts (δ) are reported in parts per million (ppm) relative to tetramethylsilane, calibrated using the deuterium signal of solvents (DMSO-d6, CD3OD, and CDCl3). 1H–1H coupling constants (J) are in hertz (Hz). Liquid Chromatography–High-Resolution Mass Spectrometry The reaction products were suspended in 100 μL of reagent alcohol (95% ethanol, 5% isopropanol, Sigma-Aldrich) to form a saturated solution and centrifuged to sediment solids. The supernatant was diluted 10-fold with the reagent alcohol, vortexed, and filtered using 0.2 μm filter vials (polytetrafluoroethylene nanofilter vials; Thomson Instrument Company, htslabs.com). A 1 μL aliquot was injected onto the chromatography column for each analysis. Separation was performed on a 50 mm × 2.1 mm C8 column (Aeris 3.6 μm widepore XB-C8, Phenomenex) maintained at 40 °C. A linear gradient of mobile phase B (acetonitrile) in mobile phase A (0 water) was delivered by a Vanquish Flex liquid chromatography system (Thermo Fisher Scientific) at a flow rate of 250 μL/min: 4 min of 0%–70% B, 1 min of 70%–95% B, followed by 6 min equilibration at 0% B. Mass spectra were acquired on a QExactive instrument (Thermo Fisher Scientific) in the alternating polarity mode using the following settings: the MS scan resolving power was 70,000; AGC target 3e6; maximum inject time 100 ms; the data-dependent MS2 scan resolving power was 17,500; AGC target 1e5; maximum inject time 50 ms; top 5 ions were selected for fragmentation with the HCD normalized collision energy of 40. Alongside MS data, UV absorbance at 220 nm was recorded on a Vanquish variable wavelength detector (Thermo Fisher Scientific). X-ray Crystallography Single Crystal X-ray diffraction: The data collection and refinements statistics for the four structures are summarized below in table format. In each case yellow crystals were mounted on a cryo-loop using a dab of paratone oil. The X-ray data sets were collected on a Rigaku MicroMax007 rotating anode (Cu) diffractometer, equipped with HyPix-Arc 150 detector and Oxford Cryosystems Cobra apparatus. The hydrogen atoms were placed in geometric positions and rode on their respective parent atom. A crystallographic information file containing all the four structures is included in Supporting Information. Synthesis The reported brominated flavanones were synthesized from the following starting flavanone materials, which were used as obtained without further purification: naringenin, 6-hydroxyflavanone, 4′-hydroxyflavanone, 5-methoxyflavanone, and 6-methoxyflavanone. 7-methoxyflavanone and 4′-methoxyflavanone were synthesized from 7-hydroxyflavanone and 4′-hydroxyflavanone as described below. 5,6-dihydroxyflavanone was synthesized following known literature procedures. All compounds were prepared as racemic mixtures and characterized using 1H NMR, 13C NMR, distortionless enhancement by polarization transfer–NMR, 1H–1H Correlated Spectroscopy, and HRMS. 3-Bromo-5-methoxyflavanone, 3-bromo-6-methoxyflavanone, 3-bromo-7-methoxyflavanone, and 3-bromo-4′-methoxyflavanone were also structurally confirmed via X-ray crystallography. Synthesis of 7-methoxyflavanone and 4′-methoxyflavanone: 7-hydroxyflavanone or 4′-hydroxyflavanone (10 mmol) was dissolved in DMF (50 mL). Potassium carbonate (15 mmol) and methyl iodide (15 mmol) were added and the resultant solution was stirred overnight. The product was extracted into ethyl acetate, washed with 10% sodium thiosulfate, and purified via column chromatography (3:1 hexanes:EtOAc). The NMR data for both products matched that reported in the literature. Representative procedure for α-bromination of flavanones using copper­(II) bromide: The starting flavanone (4 mmol) and copper­(II) bromide (4.0 mmol) were dissolved in ethyl acetate (40 mL). The resultant solution was heated at reflux for 2 h. After cooling to room temperature, the copper salts were removed via vacuum filtration. Solvent was removed in vacuo, and the crude product was purified via silica gel column chromatography (3:1 hexane:EtOAc). The purified product was recrystallized from ethanol via slow evaporation at room temperature to isolate crystals. (±)-3-Bromo-6-methoxyflavanone was isolated in 93% yield as a 50:50 mixture of cis/trans isomers. 1H NMR (CDCl3): δ 7.56–7.34 (6 H, Ar–H), 7.34 (0.5 H, d, J = 3.0 Hz, Ar–H), 7.23–7.16 (1 H, Ar–H), 7.12 (1H, d, J = 9.0 Hz, Ar–H, cis isomer), 7.02 (0.5 H, d, J = 9.3 Hz, Ar–H, tans isomer), 5.55 (0.5 H, d, J = 8.2 Hz, C2–H, trans isomer), 5.38 (0.5 H, d, J = 1.5 Hz, C2–H, cis isomer), 5.02 (0.5 H, d, J = 8.0 Hz, C-3H, trans isomer), 4.55 (0.5 H, d, J = 1.6 Hz, C-3H, cis isomer), 3.85 (1.5 H, s, OCH3), 3.82 (1.5 H, s, OCH3). 13C NMR (CDCl3): δ 186.4 (C=O),185.4 (C=O), 155.2 (C), 154.9 (C), 154.72 (C), 154.70 (C), 136.3 (C), 135.8 (C), 129.3 (CH), 128.6 (CH), 127.3 (CH), 126.27 (CH), 126.26 (CH), 126.18 (CH), 126.09 (CH), 119.5 (CH), 119.4 (CH), 118.9 (C), 118.1 (C), 108.2 (CH), 108.15 (CH), 83.9 (C2), 79.7 (C2), 55.8 (OCH3), 52.1 (C3), 51.7 (C3). HRMS (ESI): calcd for C16H14BrO3 ([M + H]+), 333.0121; found 333.0123. (±)-Cis-3-bromo-6-methoxyflavanone was isolated selectively via recrystallization from ethanol. 1H NMR (CDCl3): δ 7.56–7.42 (6 H, Ar–H), 7.23 (1 H, dd, J = 3.0, 8.5 Hz, Ar–H), 7.14 (1H, d, J = 9.0 Hz, Ar–H), 5.38 (1 H, d, J = 1.5 Hz, C2–H), 4.55 (1 H, d, J = 1.6 Hz, C3–H), 3.87 (3 H, s, OCH3). 13C NMR (CDCl3): δ 186.4 (C=O), 155.2 (C), 154.9 (C), 135.8 (C), 128.9 (CH), 128.6 (CH), 126.3 (CH), 126.1 (CH), 119.5 (CH), 118.0 (C), 108.2 (CH), 79.8 (C2), 55.9 (OCH3), 51.9 (C3). HRMS (ESI): calcd for C16H14BrO3 ([M + H]+), 333.0121; found 333.0123. Crystallographic Data for Compound (±)-3-Bromo-5-methoxyflavanone See Table for crystallographic data for (±)-3-bromo-6-methoxyflavanone. 3Bond precision:C–C = 0.0031 AWavelength = 1.54184 Cell:a = 7.8166(4)b = 9.0418(5)c = 10.4744(6) alpha = 85.032(5)beta = 73.204(5)gamma = 75.604(5)Temperature:173 K CalculatedReported Volume686.37(7)686.37(7) Space group P-1 P-1 Hall group-P 1-P 1 Moiety formulaC16 H13 Br O3C16 H13 Br O3 Sum formulaC16 H13 Br O3C16 H13 Br O3 Mr333.16333.17 Dx, g cm–3 1.6121.612 Z22 Mu (mm–1)4.1264.126 F000336.0336.0 F000′335.49 h,k,lmax9,11,139,11,13 Nref28732636 Tmin,Tmax0.814,0.8480.715,1.000 Tmin′0.814 Correction method = # Reported T Limits:Tmin = 0.715Tmax = 1.000AbsCorr = MULTI-SCANData completeness = 0.918Theta(max) = 76.307 R(reflections) = 0.0271(2524) wR2(reflections) = 0.0704(2636) S = 0.999Npar = 183 (±)-3-Bromo-5-methoxyflavanone was isolated in 84% yield as a 70:30 mixture of cis/trans isomers. 1H NMR (CDCl3): δ 7.55–7.35 (6 H, Ar–H), 6.77 (0.7 H, d, J = 8.4 Hz, Ar–H, cis isomer), 6.69 (0.3 H, d, J = 8.4 Hz, Ar–H, trans isomer), 6.60 (0.7 H, d, J = 8.4 Hz, Ar–H, cis isomer), 6.57 (0.3 H, d, J = 8.4 Hz, Ar–H, trans isomer), 5.59 (0.3 H, d, J = 6.9 Hz, C2–H, trans isomer), 5.45 (0.7 H, d, J = 1.2 Hz, C2–H, cis isomer), 4.88 (0.3 H, d, J = 6.9 Hz, C3–H, trans isomer), 4.49 (0.7 H, d, J = 1.7 Hz, C3–H, cis isomer), 3.93 (2.1 H, s, OCH3, cis isomer), 3.89 (0.9 H, s, OCH3, trans isomer). 13C NMR (CDCl3): δ 184.9 (C=O), 183.3 (C=O), 161.9 (C), 161.8 (C), 161.3 (C), 161.2 (C), 137.0 (CH), 136.8 (CH), 136.0 (C), 135.8 (C), 129.2 (CH), 128.9 (CH), 128.8 (CH), 128.5 (C), 126.9 (CH), 126.0 (C), 109.9 (CH), 109.8 (CH), 109.4 (C) 108.4 (C), 104.7 (CH), 104.6 (CH), 82.9 (C2), 78.7 (C2), 56.3 (OCH3), 56.28 (OCH3), 53.4 (C3), 51.7 (C3). Crystallographic Data for Compound (±)-3-Bromo-7-methoxyflavanone See Table for crystallographic data for (±)-3-bromo-5-methoxyflavanone. 4Bond precision:C–C = 0.0101 AWavelength = 1.54184 Cell:a = 18.5896(4)b = 7.3254(2)c = 20.3731(5) alpha = 90beta = 90gamma = 90Temperature:173 K CalculatedReported Volume2774.33(12)2774.33(12) Space group Pbca Pbca Hall group-P 2ac 2ab-P 2ac 2ab Moiety formulaC16 H13 Br O3C16 H13 Br O3 Sum formulaC16 H13 Br O3C16 H13 Br O3 Mr333.16333.17 Dx, g cm–3 1.5951.595 Z88 Mu (mm–1)4.0834.083 F0001344.01344.0 F000′1341.97 h,k,lmax23,9,2523,8,25 Nref29152788 Tmin,Tmax0.727,0.9220.800,1.000 Tmin′0.660 Correction method = # Reported T Limits:Tmin = 0.800Tmax = 1.000AbsCorr = MULTI-SCANData completeness = 0.956Theta(max) = 76.550 R(reflections) = 0.0634(2228) wR2(reflections) = 0.1931(2788) S = 1.109Npar = 201 (±)-3-Bromo-7-methoxyflavanone was isolated in 84% yield as a 67:33 mixture of cis/trans isomers. 1H NMR (CDCl3): 1H NMR (CDCl3): δ7.91 (0.7H, d, J = 8.8 Hz, Ar–H, cis isomer), 7.84 (0.3H, d, J = 8.8 Hz, Ar–H, trans isomer), 7.53–7.37 (5H, Ar–H), 6.69 (0.7 H, dd, J = 2.3 Hz, 8.8 Hz, Ar–H, cis isomer), 6.65–6.61 (1H, Ar–H), 6.49 (0.3H, d, J = 2.3 Hz, Ar–H, trans isomer), 5.54 (0.3H, d, J = 8.5 Hz, C2–H, trans isomer), 5.42 (0.7H, d, J = 1.3 Hz, C2–H, cis isomer), 4.96 (0.3H, d, J = 8.5 Hz, C3–H, trans isomer), 4.51 (0.7H, d, J = 1.8 Hz, C3–H, cis isomer), 3.85 (2H, s, OCH3, cis isomer), 3.81 (1H, s, OCH3, trans isomer). 13C NMR (CDCl3): δ 185.1 (C=O), 183.8 (C=O), 166.8, 166.7, 162.5, 162.1, 136.3, 135.8, 130.0, 129.8, 128.9, 128.8, 128.6, 127.2, 126.1, 111.8, 111.6, 111.1, 100.9, 100.8, 84.1 (C2), 79.9 (C2), 55.9 (OCH3), 55.8 (OCH3), 52.1 (C3), 51.6 (C3). HRMS (ESI): calcd for C16H14BrO3 ([M + H]+), 333.0121; found 333.0121. Crystallographic Data for Compound (±)-3-Bromo-4-methoxyflavanone See Table for crystallographic data for (±)-3-bromo-7-methoxyflavanone. 5Bond precision:C–C = 0.0063 AWavelength = 1.54184 Cell:a = 14.4643(3)b = 10.5913(3)c = 9.2047(2) alpha = 90beta = 95.141(2)gamma = 90Temperature:298 K CalculatedReported Volume1404.45(6)1404.45(6) Space group P21/c P121/c1 Hall group-P 2ybc-P 2ybc Moiety formulaC16 H13 Br O3C16 H13 Br O3 Sum formulaC16 H13 Br O3C16 H13 Br O3 Mr333.16333.17 Dx, g cm–3 1.5761.576 Z44 Mu (mm–1)4.0334.033 F000672.0672.0 F000′670.98 h,k,lmax18,13,1118,13,11 Nref29642895 Tmin,Tmax0.647,0.7240.872,1.000 Tmin′0.057 Correction method = # Reported T Limits:Tmin = 0.872Tmax = 1.000AbsCorr = MULTI-SCANData completeness= 0.977Theta(max) = 76.774 R(reflections) = 0.0504(2195) wR2(reflections) = 0.1690(2895) S = 1.075Npar = 201 (±)-3-Bromo-4′-methoxyflavanone was isolated in 84% yield as a 70:30 mixture of cis/trans isomers. 1H NMR (CDCl3): δ 8.03 (0.7 H, dd, J = 1.7 Hz, 7.9 Hz, Ar–H, cis isomer), 7.95 (0.3 H, dd, J = 1.7 Hz, 7.9 Hz, Ar–H, trans isomer), 7.61–7.35 (3H, m, Ar–H,), 7.19–6.92 (4H, m, Ar–H), 5.53 (0.3 H, d, J = 8.9 Hz, C2–H, trans isomer), 5.38 (0.7 H, app s, C2–H, cis isomer), 5.01 (0.3 H, d, J = 8.9 Hz, C3–H, trans isomer), 4.53 (0.7 H, d, J = 0.8 Hz, C3–H, cis isomer), 3.85 (2.1 H, s, OCH3, cis isomer), 3.81 (0.9 H, s, OCH3, trans isomer). 13C NMR (CDCl3): 186.5 (C=O), 185.6 (C=O), 160.6 (C), 160.3 (C), 160.1 (C), 159.9 (C), 136.9 (CH), 136.7 (CH), 128.7 (CH), 128.4 (CH), 128.3 (C), 128.0 (CH), 127.7 (C), 127.5 (CH), 122.5 (CH), 122.3 (CH), 119.1 (C), 118.2 (CH), 118.1 (C), 118.0 (CH), 114.2 (CH), 113.9 (CH), 83.6 (C2), 79.3 (C2), 55.4 (OCH3), 52.5 (C3), 52.1 (C3). HRMS (ESI): calcd for C16H14BrO3 ([M + H]+), 333.0121; found 333.0121. Crystallographic Data for Compound (±)-3-Bromo-4′-methoxyflavanone See Table for crystallographic data for (±)-3-bromo-4′-methoxyflavanone. 6Bond precision:C–C = 0.0046 AWavelength = 1.54184 Cell:a = 7.0989(4)b = 10.0140(4)c = 10.6685(7) alpha = 73.049(5)beta = 75.711(5)gamma = 70.965(4)Temperature:173 K CalculatedReported Volume676.07(7)676.07(7) Space group P-1 P-1 Hall group-P 1-P 1 Moiety formulaC16 H13 Br O3C16 H13 Br O3 Sum formulaC16 H13 Br O3C16 H13 Br O3 Mr333.16333.17 Dx,g cm–3 1.6371.637 Z22 Mu (mm–1)4.1894.189 F000336.0336.0 F000′335.49 h,k,lmax8,12,138,12,13 Nref28452682 Tmin,Tmax0.574,0.6310.653,1.000 Tmin′0.508 Correction method = # Reported T Limits:Tmin = 0.653Tmax = 1.000AbsCorr = MULTI-SCANData completeness = 0.943Theta(max) = 76.832 R(reflections) = 0.0403(2635) wR2(reflections) = 0.1137(2682) S = 1.074Npar = 183 (±)-3-Bromo-6-hydroxyflavanone was isolated in 97% yield as a 66:34 mixture of cis/trans isomers. Minor amounts of inseparable byproducts also were present. 1H NMR (CDCl3): δ 7.56–7.29 (6H, m, Ar–H), 7.20–6.94 (2H, m, Ar–H), 5.56 (0.33H, d, J = 8.4 Hz, C2–H, trans isomer), 5.49 (0.67H, d, J = 1.5 Hz, cis isomer), 5.27 (0.33H, d, J = 8.4 Hz, C3–H), 4.67 (0.67H, d, J = 1.5 Hz, C3–H, cis isomer). 13C NMR (CDCl3): 186.7 (C=O), 186.1 (C=O), 154.2, 153.7, 152.4, 152.2, 136.8, 136.5, 128.7, 128.6, 128.3, 128.1, 128.0, 127.2, 125.8, 125.3, 125.2, 118.9, 118.7, 118.3, 110.9, 110.6, 83.6, 79.2, 52.3, 51.3. HRMS (ESI): calcd for C15H11BrO3 ([M + H]+), 318.9964; found 318.9967. Crystallographic Data for 6-Hydroxyflavone Byproduct See Table for crystallographic data for 6-hydroxyflavone byproduct. 7Bond precision:C–C = 0.0041 AWavelength = 1.54184 Cell:a = 5.2333(2)b = 21.1698(10)c = 10.2817(4) alpha = 90beta = 93.155(4)gamma = 90Temperature:293 K CalculatedReported Volume1137.36(8)1137.36(8) Space group Cc C1c1 Hall groupC -2ycC -2yc Moiety formulaC15 H10 O3C15 H10 O3 Sum formulaC15 H10 O3C15 H10 O3 Mr238.23238.23 Dx, g cm–3 1.3911.391 Z44 Mu (mm–1)0.7970.797 F000496.0496.0 F000′497.62 h,k,lmax6,26,126,26,12 Nref2379[1196]1503 Tmin,Tmax0.926,0.9840.900,1.000 Tmin′0.866 Correction method = # Reported T Limits:Tmin = 0.900Tmax = 1.000AbsCorr = MULTI-SCANData completeness = 1.26/0.63Theta(max) = 76.095 R(reflections) = 0.0361(1368) wR2(reflections)= 0.0993(1503) S = 1.025Npar = 165 Supplementary Material